Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.

Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.

Item
http://www.wikidata.org/entity/Q40318288
Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion Medicine.Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.An unbalanced study that lacks power: a caution about IPTAS.Response to "An unbalanced study that lacks power: a caution about IPTAS".Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system
P2860

Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.

Item
http://www.wikidata.org/entity/Q40318288
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Clinical effectiveness of plat ...... thogen-reduction technologies.
@en
type
label
Clinical effectiveness of plat ...... thogen-reduction technologies.
@en
prefLabel
Clinical effectiveness of plat ...... thogen-reduction technologies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Clinical effectiveness of plat ...... athogen-reduction technologies
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698